Patents Assigned to Zoll Respicardia, Inc.
  • Patent number: 11883659
    Abstract: A means for treating breathing disorders by stimulating respiratory muscles or nerves to entrain respiratory systems while leaving respiratory drive intact. Embodiments of the invention employ frequency analysis to determine if appropriate stimulation energy is being applied.
    Type: Grant
    Filed: June 17, 2021
    Date of Patent: January 30, 2024
    Assignee: ZOLL RESPICARDIA, INC.
    Inventors: Mark Gelfand, Kristofer J. James, Randy W. Westlund, Antonios Panteleon, Todd P. Goblish, Mark C. Lynn
  • Patent number: 11865333
    Abstract: A medical electrical lead and methods of implanting medical electrical leads in lumens. Leads in accordance with the invention employ preformed biases to stabilize the lead within a lumen or lumen and to provide feedback to lead implanters.
    Type: Grant
    Filed: June 17, 2022
    Date of Patent: January 9, 2024
    Assignee: ZOLL RESPICARDIA, INC.
    Inventor: Randy W. Westlund
  • Publication number: 20220248978
    Abstract: Some examples of the disclosure include applications, treatment-monitoring systems and computing devices configured with the applications, and computer-implemented methods to aid user monitoring of disordered-breathing and treatment.
    Type: Application
    Filed: February 10, 2022
    Publication date: August 11, 2022
    Applicant: ZOLL RESPICARDIA, INC.
    Inventors: Antonis Panteleon, Kristofer J. James, Todd P. Goblish
  • Patent number: 11389648
    Abstract: A medical electrical lead and methods of implanting medical electrical leads in lumens. Leads in accordance with the invention employ preformed biases to stabilize the lead within a lumen or lumen and to provide feedback to lead implanters.
    Type: Grant
    Filed: December 17, 2019
    Date of Patent: July 19, 2022
    Assignee: ZOLL RESPICARDIA, INC.
    Inventor: Randy W. Westlund
  • Patent number: 11305119
    Abstract: An implantable medical device for treating breathing disorders such as central sleep apnea wherein stimulation is provided to the phrenic never through a transvenous lead system with the stimulation beginning after inspiration to extend the duration of a breath and to hold the diaphragm in a contracted condition.
    Type: Grant
    Filed: May 18, 2015
    Date of Patent: April 19, 2022
    Assignee: ZOLL RESPICARDIA, INC.
    Inventors: Mark Gelfand, Howard R. Levin, Andrew Halpert
  • Patent number: 11305114
    Abstract: A system for treating disordered breathing of a human being includes an implantable transvenous stimulation lead having at least one stimulation electrode and a sensor configured to detect activity level of the human being. The system includes an energy source, a pulse generator and circuitry, the circuitry operative to receive a signal indicative of the activity level of the human being from the sensor, wherein the circuitry is configured to cause the energy source and the pulse generator to deliver spaced apart stimulation signals to the at least one stimulation electrode while the activity level of the human being is sufficiently low to be indicative of sleep. Spaced apart stimulation pulses from the electrode are configured to extend a duration of a time of at least one breath being defined as the time from an onset of inhalation to the onset of inhalation of a successive breath.
    Type: Grant
    Filed: May 21, 2018
    Date of Patent: April 19, 2022
    Assignee: ZOLL RESPICARDIA, INC.
    Inventors: Mark Gelfand, Howard Levin, Andrew Halpert, Antonis Panteleon
  • Patent number: 11305111
    Abstract: A medical electrical lead and methods of implanting medical electrical leads in lumens. Leads in accordance with the invention employ preformed biases to stabilize the lead within a lumen and to orient electrodes in a preferred orientation.
    Type: Grant
    Filed: November 20, 2019
    Date of Patent: April 19, 2022
    Assignee: ZOLL RESPICARDIA, INC.
    Inventors: Randy W. Westlund, Mark C. Lynn
  • Patent number: 11065443
    Abstract: A means for treating breathing disorders by stimulating respiratory muscles or nerves to entrain respiratory systems while leaving respiratory drive intact. Embodiments of the invention employ frequency analysis to determine if appropriate stimulation energy is being applied.
    Type: Grant
    Filed: June 7, 2018
    Date of Patent: July 20, 2021
    Assignee: Zoll Respicardia, Inc.
    Inventors: Mark Gelfand, Kristofer J. James, Randy W. Westlund, Antonis Panteleon, Todd P. Goblish, Mark C. Lynn